Eisai
4523.T
#2144
Rank
NZ$16.02 B
Marketcap
NZ$56.79
Share price
3.73%
Change (1 day)
11.92%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Eisai (4523.T) - Net assets

Net assets on the balance sheet as of March 2026 : NZ$10.39 Billion

According to Eisai's latest financial reports the company has NZ$10.39 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Eisai - Net assets on balance sheet (from 2009 to 2024)

Net assets by year

Year Net assets Change
2023-03-31$NZ$9.86 B8.13%
2022-03-31$NZ$9.11 B-3.29%
2021-03-31$NZ$9.42 B-13.72%
2020-03-31$NZ$10.92 B26.96%
2019-03-31$NZ$8.60 B7.83%
2018-03-31$NZ$7.98 B3.85%
2017-03-31$NZ$7.68 B3.63%
2016-03-31$NZ$7.41 B10.09%
2015-03-31$NZ$6.73 B13.62%
2014-03-31$NZ$5.93 B-1.26%
2013-03-31$NZ$6.00 B-3.52%
2012-03-31$NZ$6.22 B-4.06%
2011-03-31$NZ$6.48 B1.83%
2010-03-31$NZ$6.37 B-17.43%
2009-03-31$NZ$7.71 B36.51%
2008-03-31$NZ$5.65 B-15.35%
2007-03-31$NZ$6.67 B-8.33%
2006-03-31$NZ$7.28 B20.81%
2005-03-31$NZ$6.03 B0%
2004-03-31$NZ$6.03 B1.49%
2003-03-31$NZ$5.94 B-5.97%
2002-03-31$NZ$6.31 B-8.13%
2001-03-31$NZ$6.87 B